Uri Ladabaum

Publication Details

  • Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis.

    Yen EF, Kane SV, Ladabaum U. Am J Gastroenterol. 2008; 103 (12): 3094-105

    Oral 5-aminosalicylic acid (5-ASA, mesalamine) is effective in inducing and maintaining remission in ulcerative colitis (UC). The relative benefits and costs of maintenance 5-ASA therapy are uncertain. Our aims were to evaluate this strategy's potential cost-effectiveness.

    PubMedID: 18775007

Stanford Medicine Resources:

Footer Links: